tirzepatide news october 18 2025 📣 BIG IN OBESITY MEDICINE! 🇨🇦 Health Canada has officially approved Zepbound™ KwikPen® (tirzepatide injection) for chronic weight management! Zepbound™ is a once-weekly injectable medication that works by activating two key Tirzepatide Improved Weight, Diabetes Control

Additionally, some patients report altered taste

The peptide ability to promote collagen synthesis and enhance wound healing makes topical application relevant for dermatological applications

This represents a significant consideration for healthcare providers and patients making treatment decisions

It carries a C20 fatty-diacid acylation that enables strong albumin binding and a serum half-life of approximately 6 days, supporting the once-weekly administration cadence used in published Phase 2 research literature

Some health conditions may increase the risks of taking tirzepatide, while others might make you a better candidate for it

The starting doe for dapagliflozin was 10 mg/day and for spironolactone it was 25 mg every other day if the baseline estimated glomerular filtration rate (eGFR) was 5.5 mmol/L: 5 [4.8%] vs